课题基金 / 基金详情

Construction of new gibberellin fermentation by a novel fungus phaeosphaeria sp. L487 and elucidation of its plant-like biosynthesis of gibberellin A_1

Construction of new gibberellin fermentation by a novel fungus phaeosphaeria sp. L487 and elucidation of its plant-like biosynthesis of gibberellin A_1
新型真菌Pheosphaeria sp.构建新的赤霉素发酵体系。
批准号:
06453170
负责人:
SASSA Takeshi
金额:
$3.71万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

SASSA Takeshi的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1) Gibberellin production by the novel fungus Phaeosphaeria sp.L487.Gibberellin A_1 (GA_1) formation in its fermentations using shaken Sakaguchi flasks was stimulated in the 1.5% oatmeal medium as well as in the 0.4% Pharmamedia medium.Empolying optimized growing conditions (8% glucose, 1.5% oatmeal, 0.1% NH_4NO_3), concentrations of GA,of over 200 mug/ml were reached. Further, those of GA_1 of 300mug/ml were oberved by supplement of additional 3% glucose in the middle stage of GA_1 fermentation. New fungal GA,GA_<82> was isolated for the first time as crystalline from the culture. GA_4 and GA_9 were found at concentrations of 30 and 15 mug/ml, respectively, in the medium pH-controlled with K_2HPO_4 st 6.5-7.0.2) Elucidation of plant-like biosynthesis of gibberellin in Phaeosphaeria sp. L487.Minor GAs, GA_<12>, GA_<15> and GA_<20>, from this fungus were detected by GC-MS analysis.Using several labelled-GA precusors and a GA-biosynthetic inhibitor uniconazole, new fungal plant-like biosynthesis of GA_1 was revealed as the early-non-hydroxylation pathway from GA_<12>-aldehyde to GA_1 : GA_<12>-aldehyde*GA_<12>*GA_<15>*GA_<24>*GA_9*GA_4 (GA_<20>) *GA_1・In the GA_1-biosynthetic pathway, GA_9*GA_4 and GA_<20>*GA_1 were new fungal GA-metabolic routes. Ultracentrifuged pupernatant prepared from the mycelia catalized kaurene formation from labelled mavalonate, suggesting that kaurene synthase of the fungus is a soluble enzyme.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
佐々武史: "続医薬品の開発 第18巻 農薬の開発IV 「第27章 植物ホルモンと関連天然物の構造 生合成及び生理作用」" 廣川書店, 142 (1994)
笹武:《药品的继续开发第18卷农用化学品的开发IV》第27章植物激素及相关天然产物的结构、生物合成和生理作用》广川书店,142(1994)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kawaide,Hiroshi: "Plant-like biosynthesis of gibberellin A_1 in the fungus Phaeosphaeria sp. L487." Phytochemistry. 39. 305-310 (1995)
Kawaide, Hiroshi:“真菌 Phaeosphaeria sp. L487 中赤霉素 A_1 的植物样生物合成。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
佐々武史: "真菌類の生産する植物成長調節物質に関する生物有機化学的研究" 植物の化学調節. 29. 1-14 (1994)
笹武:《真菌产生的植物生长调节剂的生物有机化学研究》《植物化学调控》29. 1-14 (1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Seto, Hideharu: "Isolation and stereocontrolled synthesis of a 17-hydroxy-16B, 17-dihydroxygibberellin, GA82." Tetrahedron Lett.36. 5917-5920 (1995)
Seto, Hideharu:“17-羟基-16B、17-二羟基赤霉素、GA82 的分离和立体控制合成。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
12
    Studies on production and improvement of terpenoids using biosynthetic gene cluster in fungi and plants.
    • 批准号:
      16208012
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.03万
    • 财政年份:
      2004
    • 负责人:
      SASSA Takeshi
    • 依托单位:
    Scientific research on elucidation of terpene-cyclic reactions in the biosynthesis of bioactive microbial terpenoids.
    • 批准号:
      13306009
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $36.03万
    • 财政年份:
      2001
    • 负责人:
      SASSA Takeshi
    • 依托单位:
    Preparation/production and Utilization Researches of Terpenoidal Plant-growth Stimulants and Other Bioactive Substances with High Bioactivity.
    • 批准号:
      12556015
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.38万
    • 财政年份:
      2000
    • 负责人:
      SASSA Takeshi
    • 依托单位:
    cDNA cloning and its development of diterpene cyclases forming its cyclic carbon skeleton from bioactive diterpene producing microorganisms
    • 批准号:
      11460053
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $9.54万
    • 财政年份:
      1999
    • 负责人:
      SASSA Takeshi
    • 依托单位: